Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC
- 5 December 2010
- Vol. 408 (1) , 1-13
- https://doi.org/10.1016/j.virol.2010.08.028
Abstract
No abstract availableKeywords
Funding Information
- NIH Center for HIV/AIDS Vaccine Immunology (CHAVI) (UO1-AI067854)
- Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive Antibody Vaccine Immune Monitoring Consortium (CA-VIMC) (38619)
- Department of Veterans Affairs Medical Center, Research Services
- NIH Training Grant (AI007439)
This publication has 60 references indexed in Scilit:
- Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost VaccinationJournal of Virology, 2010
- Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokinesThe Journal of Experimental Medicine, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infectionThe Journal of Experimental Medicine, 2009
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences, 2008
- Inhibition of HIV‐1 entry by antibodies: potential viral and cellular targetsJournal of Internal Medicine, 2007
- Monoclonal Antibodies to Phosphatidylinositol Phosphate Neutralize Human Immunodeficiency Virus Type 1: Role of Phosphate-Binding SubsitesJournal of Virology, 2007
- Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern AfricaJournal of Virology, 2006
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004